drugset / Trial / NCT07001956
The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
Phase 0
Recruiting
24 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
NaSingle-groupOpen-labelTreatment
Summary
This clinical trial is designed as a single - arm, open - label, single - center, investigator - initiated early - phase clinical study. The primary objective is to evaluate the safety of UTAA91 injection in treating subjects with refractory moderate - to - severe active rheumatoid arthritis.
Timeline
- Start
- 2025-05-30
- Primary completion
- 2027-12
- Completion
- 2040-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UTAA91 injection | Unknown | — | — |